[April 24, 2014]

Research and Markets: Global Apotex Partnering Deals 2009-2014

Research and Markets (http://www.researchandmarkets.com/research/jr6gt7/apotex_partnering) has announced the addition of the "Apotex Partnering 2009-2014" company profile to their offering.

This report provides all the information you require to better understand Apotex and its partnering interests and activities over the past seven years.

One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.

Using this report, dealmakers will effectively and efficietly target their partnering activities to deliver the company's business development objectives.

The deals are listed by deal type, stage of development and therapy focus, allowing easy access to deals and alliances of interest. Every deal record links to an online, live version of the deal record at the Current Agreements deals and alliances database. Where available, deal records also include the contract document as disclosed at the SEC (News - Alert).

One of the key aspects of partnering is conducting due diligence on a partner to determine under what terms a prospective partner agrees to a partnering relationship.

Understanding the flexibility of prospective partners' negiotated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

In addition, contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each parties ability to derive value from the deal.

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Biopharma top 50 and dealmaking activity

Chapter 3 - Top bigpharma deals by value

Chapter 4 - Submitting Opportunities to Prospective Partners

Chapter 5 - Forthcoming partnering events

Chapter 6 - Company Profile

For more information visit http://www.researchandmarkets.com/research/jr6gt7/apotex_partnering

[ Back To TMCnet.com's Homepage ]